Company profile: Ascensus Specialties
1.1 - Company Overview
Company description
- Provider of sodium borohydride, boranes, reactive and alkali metals, boronic acids and esters, and specialty alcoholates for applications in pharmaceuticals, fine chemicals, pulp processing, electronic materials, and agrochemicals. Also offers cGMP and custom synthesis, including API production.
Products and services
- Sodium Borohydride: Industrial-grade reducing agent for pharmaceuticals and pulp processing, also delivered as a catalyst, enabling selective reductions across various industrial applications with proven reactivity
- CALLERY™ Boranes: High-purity selective reducing agents for pharmaceuticals and fine chemicals, precisely reducing aldehydes, ketones, and other functional groups in synthesis
- CALLERY™ Alkali Metals: Reagent-grade highly reactive metals used in chemical synthesis and olefin isomerization, supporting pharmaceutical and fine chemical industries.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Ascensus Specialties
Minafin
HQ: France
Website
- Description: Provider of fine chemicals for life sciences and high tech, developing and manufacturing active ingredients, organic intermediates, and specialty chemicals. Offers APIs (patented, generic, HPAPIs), cosmetic and agricultural ingredients, bio-based solvents and fine chemicals, highly reactive chemistry for complex synthesis, process scale-up, high-pressure chemistry, and niche polymers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Minafin company profile →
Syra Health
HQ: United States
Website
- Description: Provider of healthcare and managed-care solutions grounded in real-world evidence and insights, including a mental and behavioral health platform for assessments, education, symptom monitoring, and interventions; an EMR to streamline clinical workflows and manage patient health information; a real-time patient engagement bot; workforce staffing and MSPs; a population health insights hub; and education and training.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Syra Health company profile →
ImmunXperts
HQ: Belgium
Website
- Description: Provider of in vitro immunology services with a strong focus on immunogenicity and immuno-oncology, helping biopharma companies select their best lead candidates by assessing immune responses in donors and patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ImmunXperts company profile →
Leukocare
HQ: Germany
Website
- Description: Provider of biopharmaceutical formulation development services operating at the interface of drug substance and drug product, combining bioinformatics, artificial intelligence and data science. Offerings include drug substance characterization, developability assessment, particle characterization, stability studies, and in silico analytics to optimize and accelerate development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Leukocare company profile →
Quotient Sciences
HQ: United Kingdom
Website
- Description: Provider of formulation development, clinical pharmacology, and clinical-to-commercial manufacturing. Services span preformulation; small-batch supply to accelerate POC; 14-day make-test cycles in humans; process development and scale-up through Phase II/III; commercial manufacturing for ANDA/NDA/MAA/Japanese NDA; and Translational Pharmaceutics integrating formulation, adaptive GMP manufacturing, and clinical research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Quotient Sciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Ascensus Specialties
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Ascensus Specialties
2.2 - Growth funds investing in similar companies to Ascensus Specialties
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Ascensus Specialties
4.2 - Public trading comparable groups for Ascensus Specialties
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →